PH31392A - Pharmaceutical compositions. - Google Patents
Pharmaceutical compositions.Info
- Publication number
- PH31392A PH31392A PH45736A PH45736A PH31392A PH 31392 A PH31392 A PH 31392A PH 45736 A PH45736 A PH 45736A PH 45736 A PH45736 A PH 45736A PH 31392 A PH31392 A PH 31392A
- Authority
- PH
- Philippines
- Prior art keywords
- group
- substituted
- hydrogen
- represents hydrogen
- halogeno
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 239000001257 hydrogen Substances 0.000 abstract 8
- 229910052739 hydrogen Inorganic materials 0.000 abstract 8
- 150000002431 hydrogen Chemical group 0.000 abstract 6
- 125000001183 hydrocarbyl group Chemical group 0.000 abstract 4
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 4
- 125000001931 aliphatic group Chemical group 0.000 abstract 3
- 125000001188 haloalkyl group Chemical group 0.000 abstract 3
- 125000005843 halogen group Chemical group 0.000 abstract 3
- 125000000623 heterocyclic group Chemical group 0.000 abstract 3
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract 2
- 239000005864 Sulphur Chemical group 0.000 abstract 2
- 125000003118 aryl group Chemical group 0.000 abstract 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 125000005842 heteroatom Chemical group 0.000 abstract 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 abstract 2
- 229910052757 nitrogen Inorganic materials 0.000 abstract 2
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 abstract 2
- 239000001301 oxygen Chemical group 0.000 abstract 2
- 229910052760 oxygen Inorganic materials 0.000 abstract 2
- 208000000044 Amnesia Diseases 0.000 abstract 1
- 208000031091 Amnestic disease Diseases 0.000 abstract 1
- 208000019901 Anxiety disease Diseases 0.000 abstract 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 125000002723 alicyclic group Chemical group 0.000 abstract 1
- 230000006986 amnesia Effects 0.000 abstract 1
- 230000036506 anxiety Effects 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 150000007522 mineralic acids Chemical class 0.000 abstract 1
- 150000007524 organic acids Chemical class 0.000 abstract 1
- 125000004043 oxo group Chemical group O=* 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/20—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings condensed with carbocyclic rings or ring systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Anesthesiology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB929203500A GB9203500D0 (en) | 1992-02-19 | 1992-02-19 | Pharmaceutical compositions |
| GB9300921A GB2264299B (en) | 1992-02-19 | 1993-01-19 | Iso-oxazolidine derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PH31392A true PH31392A (en) | 1998-10-29 |
Family
ID=26300339
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PH45736A PH31392A (en) | 1992-02-19 | 1993-02-17 | Pharmaceutical compositions. |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US5476867A (fr) |
| EP (1) | EP0626951B1 (fr) |
| JP (1) | JP3464479B2 (fr) |
| KR (1) | KR100274479B1 (fr) |
| AT (1) | ATE169010T1 (fr) |
| AU (1) | AU677176B2 (fr) |
| CA (1) | CA2117471C (fr) |
| DE (1) | DE69320030T2 (fr) |
| DK (1) | DK0626951T3 (fr) |
| ES (1) | ES2121075T3 (fr) |
| GB (1) | GB2264299B (fr) |
| IL (1) | IL104771A (fr) |
| NO (1) | NO305027B1 (fr) |
| PH (1) | PH31392A (fr) |
| WO (1) | WO1993017004A1 (fr) |
| ZA (1) | ZA931190B (fr) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9226857D0 (en) * | 1992-12-23 | 1993-02-17 | Boyd Edward A | Pharmaceutical compositions |
| US7115666B2 (en) * | 2002-10-15 | 2006-10-03 | Renovis, Inc. | Nitrone compounds, pharmaceutical compositions containing the same and methods for treating inflammation and neuropathic pain |
| RU2006101055A (ru) * | 2003-06-12 | 2006-07-10 | Би Ти Джи Интернэшнл Лимитед (Gb) | Циклические гидроксиламины как психотропные соединения |
| ITMI20062102A1 (it) * | 2006-11-02 | 2008-05-03 | Abiogen Pharma Spa | Nuovui sali di 3-benzil-2-metil-2,3,3a,4,5,6,7,7a-ottaidrobenzo-d-isossazol-4-one |
| EP2112142A1 (fr) * | 2008-04-24 | 2009-10-28 | Abiogen Pharma S.p.A. | Procédé de préparation d'une forme cristalline du 3-benzyl-2-methyl-2,3,3a,4,5,6,7,7a-octahydrobenzo[d]isoxazol-4-one |
| ITMI20080768A1 (it) * | 2008-04-24 | 2009-10-25 | Abiogen Pharma Spa | Procedimento per la preparazione di un composto in forma cristallina di 3-benzil-2-metil-2,3,3a,4,5,6,7,7a-ottaidro-benzo[d]isossazol-4-one |
| WO2011010332A1 (fr) * | 2009-07-23 | 2011-01-27 | Abiogen Pharma S.P.A. | Procédé de préparation de rel-(3r*,3as*,7as*)-3-benzyl-2-méthyl-2,3, 3a,4,5,6,7,7a-octahydrobenzo[d]isoxazol-4-one ou de l'un de ses sels |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1540580A (en) * | 1975-09-02 | 1979-02-14 | Shell Int Research | Fungicidal isoxazolidines |
| US4452799A (en) * | 1981-12-23 | 1984-06-05 | Mead Johnson & Company | Benzisothiazole and benzisoxazole piperazine derivatives |
| US5049564A (en) * | 1989-11-17 | 1991-09-17 | Abbott Laboratories | 5-HT selective agents |
| US5114960A (en) * | 1989-07-20 | 1992-05-19 | Hoffmann-La Roche Inc. | Substituted isoxazole derivatives |
| US5114936A (en) * | 1990-08-23 | 1992-05-19 | Hoechst-Roussel Pharmaceuticals Incorporated | 6,7-dihydro-3-phenyl-1,2-benzisoxazol-4(5h)-ones and -ols, compositions and pharmaceutical use |
-
1993
- 1993-01-19 GB GB9300921A patent/GB2264299B/en not_active Revoked
- 1993-02-17 PH PH45736A patent/PH31392A/en unknown
- 1993-02-17 IL IL10477193A patent/IL104771A/en not_active IP Right Cessation
- 1993-02-18 DK DK93904218T patent/DK0626951T3/da active
- 1993-02-18 JP JP51462393A patent/JP3464479B2/ja not_active Expired - Fee Related
- 1993-02-18 KR KR1019940702883A patent/KR100274479B1/ko not_active Expired - Fee Related
- 1993-02-18 WO PCT/GB1993/000334 patent/WO1993017004A1/fr not_active Ceased
- 1993-02-18 AU AU35086/93A patent/AU677176B2/en not_active Ceased
- 1993-02-18 AT AT93904218T patent/ATE169010T1/de active
- 1993-02-18 DE DE69320030T patent/DE69320030T2/de not_active Expired - Lifetime
- 1993-02-18 ES ES93904218T patent/ES2121075T3/es not_active Expired - Lifetime
- 1993-02-18 CA CA002117471A patent/CA2117471C/fr not_active Expired - Lifetime
- 1993-02-18 EP EP93904218A patent/EP0626951B1/fr not_active Expired - Lifetime
- 1993-02-19 ZA ZA931190A patent/ZA931190B/xx unknown
-
1994
- 1994-08-15 US US08/290,752 patent/US5476867A/en not_active Expired - Lifetime
- 1994-08-17 NO NO943042A patent/NO305027B1/no not_active IP Right Cessation
-
1995
- 1995-06-07 US US08/478,142 patent/US5578626A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| AU3508693A (en) | 1993-09-13 |
| KR950700264A (ko) | 1995-01-16 |
| EP0626951B1 (fr) | 1998-07-29 |
| NO943042D0 (no) | 1994-08-17 |
| GB2264299A (en) | 1993-08-25 |
| US5578626A (en) | 1996-11-26 |
| GB2264299B (en) | 1995-07-26 |
| JPH07504181A (ja) | 1995-05-11 |
| CA2117471A1 (fr) | 1993-09-02 |
| ZA931190B (en) | 1994-08-19 |
| WO1993017004A1 (fr) | 1993-09-02 |
| NO305027B1 (no) | 1999-03-22 |
| ATE169010T1 (de) | 1998-08-15 |
| ES2121075T3 (es) | 1998-11-16 |
| CA2117471C (fr) | 2003-04-22 |
| JP3464479B2 (ja) | 2003-11-10 |
| DE69320030T2 (de) | 1998-12-10 |
| US5476867A (en) | 1995-12-19 |
| DE69320030D1 (de) | 1998-09-03 |
| EP0626951A1 (fr) | 1994-12-07 |
| IL104771A (en) | 1998-07-15 |
| AU677176B2 (en) | 1997-04-17 |
| DK0626951T3 (da) | 1999-02-15 |
| GB9300921D0 (en) | 1993-03-10 |
| KR100274479B1 (ko) | 2000-12-15 |
| NO943042L (no) | 1994-08-17 |
| IL104771A0 (en) | 1994-05-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL87795A0 (en) | Benzimidazoline-2-oxo-1-carboxylic acid derivatives,their preparation and pharmaceutical compositions containing them | |
| DK0580502T3 (da) | 3-(hydroxybenzylidenyl)-indolin-2-oner og farmaceutiske sammensætninger indeholdende disse | |
| DE69428142D1 (de) | Quinolin- oder Quinazolinderivate, deren Herstellung und Verwendung | |
| GB9300921D0 (en) | Pharmaceutical compositions | |
| DE59209553D1 (de) | 1,7-anellierte 3-(Piperazino-alkyl)indol-Derivate sowie Verfahren und Zwischenprodukte zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel | |
| ES8101589A1 (es) | Un procedimiento para la preparacion de nuevos compuestos iminicos heterociclicos. | |
| IL108135A0 (en) | Pharmaceutical compositions containing benzoisoxazoles |